TREATMENT OF PARKINSON'S DISEASE WITH NOVEL DOPAMINE D2 AGONIST SK&F 101468
- 24 June 1989
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 333 (8652) , 1445-1446
- https://doi.org/10.1016/s0140-6736(89)90146-3
Abstract
No abstract availableThis publication has 2 references indexed in Scilit:
- ROLE OF SUBCUTANEOUS APOMORPHINE IN PARKINSONIAN VOIDING DYSFUNCTIONThe Lancet, 1988
- 4-[2-(Di-n-propylamino)ethyl]-2(3H)-indolone: a prejunctional dopamine receptor agonistJournal of Medicinal Chemistry, 1985